$NPSP Recent News 15 small-cap stocks Goldman
Post# of 44990
Posted On: 09/11/2014 12:16:29 PM
$NPSP Recent News
15 small-cap stocks Goldman Sachs says are worth a look 11:51 a.m. July 22, 2014 - blogs.marketwatch.com
Nasdaq rattles cage on major resistance 10:31 a.m. June 5, 2014 - Michael Ashbaugh
3 best hedge fund managers of 2013 2:50 p.m. Jan. 22, 2014 - Insider Monkey
This is not a bursting bubble 2:06 p.m. Jan. 14, 2014 - The Trading Deck
Charting the S&P 500’s next technical target 12:43 p.m. Dec. 19, 2013 - Michael Ashbaugh
Hedge funder Michael Castor's top pick for 2016 11:58 a.m. Sept. 20, 2013 - The Trading Deck
Charting a market divergence 11:21 a.m. Aug. 22, 2013 - Michael Ashbaugh
Manager David Simon's top three stock picks 11:03 a.m. July 26, 2013 - The Trading Deck
Charting a Fed-induced market whipsaw 11:38 a.m. May 23, 2013 - Michael Ashbaugh
3 stock picks from the next David Einhorn 8:01 a.m. March 29, 2013 - The Trading Deck
6 gut checks before the stock market's opening bell 7:43 a.m. March 20, 2013 - Shawn Langlois
Major U.S. benchmarks reach firmer ground 12:11 p.m. Nov. 29, 2012 - Michael Ashbaugh
Charting the bull/bear debate 2:06 p.m. Nov. 20, 2012 - Michael Ashbaugh
Charting the bull/bear debate 1:42 p.m. Nov. 20, 2012 - Michael Ashbaugh
Friday’s biggest gaining and declining stocks 4:33 p.m. June 22, 2012 - MarketWatch
NPS jumps on EU regulatory update 1:58 p.m. June 22, 2012 - Val Brickates Kennedy
Monday’s biggest gaining and declining stocks 5:17 p.m. Oct. 31, 2011 - Kate Gibson
NPS Pharmaceuticals plunges on drug study 12:48 p.m. Oct. 31, 2011 - Val Brickates Kennedy
Monday’s biggest gaining and declining stocks 5:35 p.m. Jan. 31, 2011 - Kate Gibson
Depomed, NPS lead drug stocks higher 5:19 p.m. Jan. 31, 2011 - Val Brickates Kennedy
Perilous Reversal Watch: NPS Pharmaceuticals (NPSP) 9:46 a.m. Today - TheStreet.com
Does New Data Make or Break NPS Pharmaceuticals? 2:18 p.m. Sept. 10, 2014 - 247WallSt.com
Why NPS Pharmaceuticals (NPSP) Stock is Surging Today 1:11 p.m. Sept. 10, 2014 - TheStreet.com
Biotech Stock Roundup: AbbVie Ties Up with Infinity, Keryx Slips on FDA Approval - Analyst Blog 11:17 a.m. Sept. 10, 2014 - Zacks.com
Benzinga's Volume Movers 9:20 a.m. Sept. 10, 2014 - benzinga.com
Natpara Ad Comm review on tap for Friday 9:00 a.m. Sept. 10, 2014 - Seeking Alpha
Heavy Volume And Pre-Market Movement For NPS Pharmaceuticals (NPSP) 8:58 a.m. Sept. 10, 2014 - TheStreet.com
Hottest Healthcare Stocks Now – NPSP LGND AVNR AUXL 8:45 a.m. Sept. 10, 2014 - InvestorPlace.com
FDA Posts Briefing Materials For Advisory Committee Meeting Reviewing Natpara For Hypoparathyroidism 7:07 a.m. Sept. 10, 2014 - benzinga.com
Hottest Healthcare Stocks Now – PTCT NPSP UTHR OPK 2:00 p.m. Sept. 8, 2014 - InvestorPlace.com
NPS Pharmaceuticals, Inc. (NPSP): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report 8:00 a.m. Sept. 5, 2014 - Zacks.com
Bearish sell-off in NPS Pharma ahead of Ad Comm meeting 3:41 p.m. Sept. 4, 2014 - Seeking Alpha
NPS Pharma: Important Catalyst Coming Next Week 4:52 p.m. Sept. 3, 2014 - Seeking Alpha
Biggest Movers in Healthcare Stocks Now – NPSP PRXL GB THOR 1:00 p.m. Sept. 3, 2014 - InvestorPlace.com
Biggest Movers in Healthcare Stocks Now – AVNR NPSP IRWD DGX 2:00 p.m. Aug. 29, 2014 - InvestorPlace.com
NPS Pharma Reports Earnings in Q2 on Strong Gattex Sales - Analyst Blog 12:40 p.m. Aug. 7, 2014 - Zacks.com
NPS Pharmaceuticals' (NPSP) CEO Francois Nader on Q2 2014 Results - Earnings Call Transcript 11:39 p.m. Aug. 6, 2014 - Seeking Alpha
NPS Pharmaceuticals (NPSP) Q2 2014 Results - Earnings Call Webcast 4:55 p.m. Aug. 6, 2014 - Seeking Alpha
Goldman's picks in small caps 12:45 p.m. Aug. 5, 2014 - Seeking Alpha
2nd Half Of 2014 Biotechnology Catalysts-Part 3 2:36 p.m. Aug. 4, 2014 - Seeking Alpha
FDA Posts Briefing Materials for Advisory Committee Meeting Reviewing Natpara® for Hypoparathyroidism 8:05 a.m. Sept. 10, 2014 - BusinessWire - BZX
Acucela Appoints Biotechnology Industry Veteran and Former Pharmaceutical Executive, Brian O’Callaghan, as Its New President and Chief Operating Officer and Interim CFO; Ryo Kubota, MD, PhD, to Remain in His Role as Chairman and CEO 8:15 p.m. Sept. 8, 2014 - BusinessWire - BZX
Critical Alerts For Apple, Kinder Morgan, Stratasys, Intercept Pharmaceuticals and NPS Pharmaceuticals Released By InvestorsObserver 9:31 a.m. Sept. 8, 2014 - PR Newswire - PRF
Biotech Equities Technical Review -- Celldex Therapeutics, Synthetic Biologics, Geron, Catalyst Pharmaceutical Partners, and NPS Pharmaceuticals 9:15 a.m. Sept. 8, 2014 - PR Newswire - PRF
NPS Pharma Reports Second-Quarter 2014 Financial Results 12:07 a.m. Aug. 7, 2014 - BusinessWire - BZX
Critical Alerts For NPS Pharmaceuticals, Qualys, General Motors, Lockheed Martin, and Navistar International Released By InvestorsObserver 9:31 a.m. Aug. 6, 2014 - PR Newswire - PRF
Biotech Equities Roundup -- Keryx Biopharma, Vertex Pharma, NPS Pharma, Cubist Pharma, and Idera Pharma 8:50 a.m. Aug. 6, 2014 - PR Newswire - PRF
NPS Pharma to Present at Upcoming Conferences 8:11 a.m. Aug. 5, 2014 - BusinessWire - BZX
NPS Pharma Initiates Phase 2a Study of NPSP795 in Adult Patients with Autosomal Dominant Hypocalcemia (ADH) 8:10 a.m. Aug. 4, 2014 - BusinessWire - BZX
Financial Results, Clinical Trial Initiations, Drug Designations, Appointments, and Study Results - Research Reports on Cubist, Jazz, InterMune, NPS Pharmaceuticals and ACADIA 9:00 a.m. July 30, 2014 - PR Newswire - PRF
NPS Pharma to Report Second Quarter 2014 Financial Results 8:10 a.m. July 29, 2014 - BusinessWire - BZX
PARADOX Findings Published in Endocrine Practice Describe High Burden of Illness in Patients with Hypoparathyroidism 8:47 a.m. July 24, 2014 - BusinessWire - BZX
Agreements, NDA Submissions, FDA Approvals, Enrollment Updates, and Index Inclusions - Analyst Notes on Jazz Pharmaceuticals, Vertex, NPS, StemCells and Achillion 5:50 a.m. July 7, 2014 - PR Newswire - PRF
FDA Approves Updated Labeling for Gattex® (Teduglutide [rDNA origin]) for Injection to Include Long-Term Data 8:31 a.m. June 30, 2014 - BusinessWire - BZX
Biotechnology Equities Movers and Shakers -- Research on ZIOPHARM Oncology, Clovis Oncology, Arrowhead Research, and NPS Pharma 7:50 a.m. June 27, 2014 - PR Newswire - PRF
Upcoming Conferences, Tentative Meeting Schedules, Analyst Day, Public Offerings, and Data Presentations - Analyst Notes on Incyte, NPS Pharmaceuticals, Arrowhead, Novavax and Chelsea Therapeutics 5:00 a.m. June 17, 2014 - PR Newswire - PRF
NPS Pharma Reports Change in Tentative Date of FDA Advisory Committee Review of Natpara® BLA to September 12 - PDUFA Date of October 24 Remains Unchanged 8:31 a.m. June 10, 2014 - BusinessWire - BZX
Critical Alerts For SunPower, Broadcom, NPS Pharmaceuticals, General Motors, and YY Technology Released By InvestorsObserver 9:31 a.m. June 9, 2014 - PR Newswire - PRF
NPS Pharma to Present at Goldman Sachs Global Healthcare Conference 4:10 p.m. June 3, 2014 - BusinessWire - BZX
SHAREHOLDER ALERT: Pomerantz LLP Investigates Claims That the Merger May Not Be in the Best Interest of Investors of NPS Pharmaceuticals, Inc. - NPSP 12:34 p.m. June 2, 2014 - PR Newswire - PRF
15 small-cap stocks Goldman Sachs says are worth a look 11:51 a.m. July 22, 2014 - blogs.marketwatch.com
Nasdaq rattles cage on major resistance 10:31 a.m. June 5, 2014 - Michael Ashbaugh
3 best hedge fund managers of 2013 2:50 p.m. Jan. 22, 2014 - Insider Monkey
This is not a bursting bubble 2:06 p.m. Jan. 14, 2014 - The Trading Deck
Charting the S&P 500’s next technical target 12:43 p.m. Dec. 19, 2013 - Michael Ashbaugh
Hedge funder Michael Castor's top pick for 2016 11:58 a.m. Sept. 20, 2013 - The Trading Deck
Charting a market divergence 11:21 a.m. Aug. 22, 2013 - Michael Ashbaugh
Manager David Simon's top three stock picks 11:03 a.m. July 26, 2013 - The Trading Deck
Charting a Fed-induced market whipsaw 11:38 a.m. May 23, 2013 - Michael Ashbaugh
3 stock picks from the next David Einhorn 8:01 a.m. March 29, 2013 - The Trading Deck
6 gut checks before the stock market's opening bell 7:43 a.m. March 20, 2013 - Shawn Langlois
Major U.S. benchmarks reach firmer ground 12:11 p.m. Nov. 29, 2012 - Michael Ashbaugh
Charting the bull/bear debate 2:06 p.m. Nov. 20, 2012 - Michael Ashbaugh
Charting the bull/bear debate 1:42 p.m. Nov. 20, 2012 - Michael Ashbaugh
Friday’s biggest gaining and declining stocks 4:33 p.m. June 22, 2012 - MarketWatch
NPS jumps on EU regulatory update 1:58 p.m. June 22, 2012 - Val Brickates Kennedy
Monday’s biggest gaining and declining stocks 5:17 p.m. Oct. 31, 2011 - Kate Gibson
NPS Pharmaceuticals plunges on drug study 12:48 p.m. Oct. 31, 2011 - Val Brickates Kennedy
Monday’s biggest gaining and declining stocks 5:35 p.m. Jan. 31, 2011 - Kate Gibson
Depomed, NPS lead drug stocks higher 5:19 p.m. Jan. 31, 2011 - Val Brickates Kennedy
Perilous Reversal Watch: NPS Pharmaceuticals (NPSP) 9:46 a.m. Today - TheStreet.com
Does New Data Make or Break NPS Pharmaceuticals? 2:18 p.m. Sept. 10, 2014 - 247WallSt.com
Why NPS Pharmaceuticals (NPSP) Stock is Surging Today 1:11 p.m. Sept. 10, 2014 - TheStreet.com
Biotech Stock Roundup: AbbVie Ties Up with Infinity, Keryx Slips on FDA Approval - Analyst Blog 11:17 a.m. Sept. 10, 2014 - Zacks.com
Benzinga's Volume Movers 9:20 a.m. Sept. 10, 2014 - benzinga.com
Natpara Ad Comm review on tap for Friday 9:00 a.m. Sept. 10, 2014 - Seeking Alpha
Heavy Volume And Pre-Market Movement For NPS Pharmaceuticals (NPSP) 8:58 a.m. Sept. 10, 2014 - TheStreet.com
Hottest Healthcare Stocks Now – NPSP LGND AVNR AUXL 8:45 a.m. Sept. 10, 2014 - InvestorPlace.com
FDA Posts Briefing Materials For Advisory Committee Meeting Reviewing Natpara For Hypoparathyroidism 7:07 a.m. Sept. 10, 2014 - benzinga.com
Hottest Healthcare Stocks Now – PTCT NPSP UTHR OPK 2:00 p.m. Sept. 8, 2014 - InvestorPlace.com
NPS Pharmaceuticals, Inc. (NPSP): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report 8:00 a.m. Sept. 5, 2014 - Zacks.com
Bearish sell-off in NPS Pharma ahead of Ad Comm meeting 3:41 p.m. Sept. 4, 2014 - Seeking Alpha
NPS Pharma: Important Catalyst Coming Next Week 4:52 p.m. Sept. 3, 2014 - Seeking Alpha
Biggest Movers in Healthcare Stocks Now – NPSP PRXL GB THOR 1:00 p.m. Sept. 3, 2014 - InvestorPlace.com
Biggest Movers in Healthcare Stocks Now – AVNR NPSP IRWD DGX 2:00 p.m. Aug. 29, 2014 - InvestorPlace.com
NPS Pharma Reports Earnings in Q2 on Strong Gattex Sales - Analyst Blog 12:40 p.m. Aug. 7, 2014 - Zacks.com
NPS Pharmaceuticals' (NPSP) CEO Francois Nader on Q2 2014 Results - Earnings Call Transcript 11:39 p.m. Aug. 6, 2014 - Seeking Alpha
NPS Pharmaceuticals (NPSP) Q2 2014 Results - Earnings Call Webcast 4:55 p.m. Aug. 6, 2014 - Seeking Alpha
Goldman's picks in small caps 12:45 p.m. Aug. 5, 2014 - Seeking Alpha
2nd Half Of 2014 Biotechnology Catalysts-Part 3 2:36 p.m. Aug. 4, 2014 - Seeking Alpha
FDA Posts Briefing Materials for Advisory Committee Meeting Reviewing Natpara® for Hypoparathyroidism 8:05 a.m. Sept. 10, 2014 - BusinessWire - BZX
Acucela Appoints Biotechnology Industry Veteran and Former Pharmaceutical Executive, Brian O’Callaghan, as Its New President and Chief Operating Officer and Interim CFO; Ryo Kubota, MD, PhD, to Remain in His Role as Chairman and CEO 8:15 p.m. Sept. 8, 2014 - BusinessWire - BZX
Critical Alerts For Apple, Kinder Morgan, Stratasys, Intercept Pharmaceuticals and NPS Pharmaceuticals Released By InvestorsObserver 9:31 a.m. Sept. 8, 2014 - PR Newswire - PRF
Biotech Equities Technical Review -- Celldex Therapeutics, Synthetic Biologics, Geron, Catalyst Pharmaceutical Partners, and NPS Pharmaceuticals 9:15 a.m. Sept. 8, 2014 - PR Newswire - PRF
NPS Pharma Reports Second-Quarter 2014 Financial Results 12:07 a.m. Aug. 7, 2014 - BusinessWire - BZX
Critical Alerts For NPS Pharmaceuticals, Qualys, General Motors, Lockheed Martin, and Navistar International Released By InvestorsObserver 9:31 a.m. Aug. 6, 2014 - PR Newswire - PRF
Biotech Equities Roundup -- Keryx Biopharma, Vertex Pharma, NPS Pharma, Cubist Pharma, and Idera Pharma 8:50 a.m. Aug. 6, 2014 - PR Newswire - PRF
NPS Pharma to Present at Upcoming Conferences 8:11 a.m. Aug. 5, 2014 - BusinessWire - BZX
NPS Pharma Initiates Phase 2a Study of NPSP795 in Adult Patients with Autosomal Dominant Hypocalcemia (ADH) 8:10 a.m. Aug. 4, 2014 - BusinessWire - BZX
Financial Results, Clinical Trial Initiations, Drug Designations, Appointments, and Study Results - Research Reports on Cubist, Jazz, InterMune, NPS Pharmaceuticals and ACADIA 9:00 a.m. July 30, 2014 - PR Newswire - PRF
NPS Pharma to Report Second Quarter 2014 Financial Results 8:10 a.m. July 29, 2014 - BusinessWire - BZX
PARADOX Findings Published in Endocrine Practice Describe High Burden of Illness in Patients with Hypoparathyroidism 8:47 a.m. July 24, 2014 - BusinessWire - BZX
Agreements, NDA Submissions, FDA Approvals, Enrollment Updates, and Index Inclusions - Analyst Notes on Jazz Pharmaceuticals, Vertex, NPS, StemCells and Achillion 5:50 a.m. July 7, 2014 - PR Newswire - PRF
FDA Approves Updated Labeling for Gattex® (Teduglutide [rDNA origin]) for Injection to Include Long-Term Data 8:31 a.m. June 30, 2014 - BusinessWire - BZX
Biotechnology Equities Movers and Shakers -- Research on ZIOPHARM Oncology, Clovis Oncology, Arrowhead Research, and NPS Pharma 7:50 a.m. June 27, 2014 - PR Newswire - PRF
Upcoming Conferences, Tentative Meeting Schedules, Analyst Day, Public Offerings, and Data Presentations - Analyst Notes on Incyte, NPS Pharmaceuticals, Arrowhead, Novavax and Chelsea Therapeutics 5:00 a.m. June 17, 2014 - PR Newswire - PRF
NPS Pharma Reports Change in Tentative Date of FDA Advisory Committee Review of Natpara® BLA to September 12 - PDUFA Date of October 24 Remains Unchanged 8:31 a.m. June 10, 2014 - BusinessWire - BZX
Critical Alerts For SunPower, Broadcom, NPS Pharmaceuticals, General Motors, and YY Technology Released By InvestorsObserver 9:31 a.m. June 9, 2014 - PR Newswire - PRF
NPS Pharma to Present at Goldman Sachs Global Healthcare Conference 4:10 p.m. June 3, 2014 - BusinessWire - BZX
SHAREHOLDER ALERT: Pomerantz LLP Investigates Claims That the Merger May Not Be in the Best Interest of Investors of NPS Pharmaceuticals, Inc. - NPSP 12:34 p.m. June 2, 2014 - PR Newswire - PRF
(0)
(0)